logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Metabolite Safety In Drug Development 1st Edition Suzanne L Iverson

  • SKU: BELL-5479700
Metabolite Safety In Drug Development 1st Edition Suzanne L Iverson
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Metabolite Safety In Drug Development 1st Edition Suzanne L Iverson instant download after payment.

Publisher: Wiley
File Extension: PDF
File size: 4.95 MB
Pages: 352
Author: Suzanne L. Iverson, Dennis A. Smith
ISBN: 9781118949658, 111894965X
Language: English
Year: 2016
Edition: 1

Product desciption

Metabolite Safety In Drug Development 1st Edition Suzanne L Iverson by Suzanne L. Iverson, Dennis A. Smith 9781118949658, 111894965X instant download after payment.

A reference on drug metabolism and metabolite safety in the development phase, this book reviews the analytical techniques and experimental designs critical for metabolite studies. It features case studies of lessons learned and real world examples, along with regulatory perspectives from the US FDA and EMA.
•    Reviews the analytical techniques and experimental designs critical for metabolite studies
•    Covers methods including chirality, species differences, mass spectrometry, radiolabels, and in vitro / in vivo correlation
•    Discusses target pharmacology, in vitro systems aligned to toxicity tests, and drug-drug interactions
•    Includes perspectives from authors with firsthand involvement in industry and the study of drug metabolites, including viewpoints that have influenced regulatory guidelines

Related Products